The majority of patients with achondroplasia have one of two variants in the fibroblast growth factor receptor 3 (FGFR3) gene, resulting in the amino acid change p.Gly380Arg [1–3]; in 75–80% of cases the mutation occurs de novo [1–3]. The gene discussed is FGFR3; the disease is achondroplasia.